BSE Live
Dec 03, 14:16Prev. Close
353.50
Open Price
354.30
Bid Price (Qty.)
351.75 (15)
Offer Price (Qty.)
354.15 (16)
NSE Live
Dec 03, 14:16Prev. Close
353.95
Open Price
353.95
Bid Price (Qty.)
352.60 (9)
Offer Price (Qty.)
353.35 (3)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -26.06 | 4.21 | -62.75 | -93.58 | -12.88 | |
| Net CashFlow From Operating Activities | 3.94 | 37.27 | -10.74 | -52.69 | 38.27 | |
| Net Cash Used In Investing Activities | -60.60 | -51.01 | 2.41 | 39.54 | -37.32 | |
| Net Cash Used From Financing Activities | 90.07 | 12.82 | 9.01 | 9.83 | -7.20 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 33.41 | -0.91 | 0.67 | -3.32 | -6.26 | |
| Cash And Cash Equivalents Begin of Year | 5.09 | 6.01 | 5.33 | 8.66 | 14.92 | |
| Cash And Cash Equivalents End Of Year | 38.50 | 5.09 | 6.01 | 5.33 | 8.66 |
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y